반응식
[CH3:1][C@H:2]1[CH2:7][N:6]([C:8]2[O:9][C:10]3[C:11](=[C:13]([C:17]([OH:19])=O)[CH:14]=[CH:15][CH:16]=3)[N:12]=2)[CH2:5][C@@H:4]([CH3:20])[O:3]1.Cl.Cl.[NH2:23][C@H:24]1[CH:29]2[CH2:30][CH2:31][N:26]([CH2:27][CH2:28]2)[CH2:25]1>>[N:26]12[CH2:25][C@@H:24]([NH:23][C:17]([C:13]3[CH:14]=[CH:15][CH:16]=[C:10]4[O:9][C:8]([N:6]5[CH2:5][C@@H:4]([CH3:20])[O:3][C@@H:2]([CH3:1])[CH2:7]5)=[N:12][C:11]=34)=[O:19])[CH:29]([CH2:30][CH2:31]1)[CH2:28][CH2:27]2참가 물질
3
실험 절차
Following general procedure GP-C1, a mixture of 2-[(2S,6R)-2,6-dimethylmorpholino]benzoxazole-4-carboxylic acid and (S)-(−)-3-aminoquinuclidine dihydrochloride were coupled to provide (S)—N-(quinuclidine-8-yl)-2-((2S,6R)-2,6-dimethylmorpholino)benzoxazole-4-carboxamide, which was converted to the hydrochloride salt following general procedure GP-D1. 1H NMR and MS consistent.
출처 및 근거
- ORD 기록
- ord-f1b8af22538b425c9246877a3c221908
- 출처 데이터셋
- uspto-grants-2011_01
- 특허 번호
- US07863271B2
연결된 노트
불러오는 중…